sábado, 12 de noviembre de 2022

High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trial - The Lancet Regional Health – Europe

High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trial - The Lancet Regional Health – Europe

No hay comentarios:

Publicar un comentario